Singlera
singlera.com.cn
Actively hiring
Commerce
Biotechnology
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Team
51-200
employees, estimated range
Backers
1
LAV
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
Backed byfrom the funds' portfolios and accelerator catalogs
LAV Overview
自2014年成立，鹍远生物一直以攻克癌症早期筛查与诊断为目标，公司基于分子诊断技术开发了一系列肿瘤和遗传疾病的基因检测解决方案。作为甲基化检测技术的引领者和推动者，鹍远生物提供高发癌症的风险评估、早筛早诊、用药指导及术后监测的全周期服务。公司拥有丰富的产品管线，覆盖泛癌种、肺癌、结直肠癌、肝癌、胃癌、食道癌、胰腺癌、甲状腺癌等。.
News
Singlera Genomics announces research collaboration with the University of Pittsburgh to advance pancreatic cancer early detection
LA JOLLA, Calif., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Singlera Genomics, a company focused on the application of novel DNA methylation technologies to genetic diagnosis, with their partner Breakthrough Genomics, a leader in the clinical analysis of genomic
Read more
Report
Singlera Genomics Inc.
Research outputs, collaborations and relationships for Singlera Genomics Inc.
Read more
Report
Singlera Genomics Presented Non-Invasive Testicular Toxicity Detection with Astellas at 2025 SOT Meeting
SAN DIEGO, March 24, 2025 (GLOBE NEWSWIRE) -- Singlera Genomics presented results showing a refined approach to detect drug-induced testicular toxicity using Singlera's cell-free DNA methylation technology with Astellas during the SOT 2025 Annual Meeting.
Read more
Report
Singlera Genomics presents results of PDACatch preclinical study at HM Hospitals Annual Early Detection Meeting
SAN DIEGO, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Singlera Genomics, a company focused on the application of novel DNA methylation technologies to genetic diagnosis, presented the results of its initial preclinical study of the PDACatch test, an assay to detec
Read more
Report
Singlera Genomics and Astellas Present Methylation-based Organ Toxicity Detection at 2024 JSOT Annual Meeting
Read more
Report
Singlera Genomics and Fudan University unveil results showing Pan-Cancer Early Detection in the Taizhou Longitudinal Study
Read more
Report
Singlera Genomics Raises $60 Million in Series A+ Financing
/PRNewswire/ -- Singlera Genomics, a non-invasive genetic diagnostics company that focuses on early-stage cancer detection, today announced that it has...
Read more
Report